LifeSciVoiceFashion Trends and Culture

R&D
- Research & Development
  
  BioMed X Launches XBridge Program to Support U.S. Reacsearchers Amid NIH Funding Cuts
  
  Editorial Team - April 8, 2025 0
  
  As research institutions throughout the United States grapple with increasing instability, many are being forced to respond to the growing consequences of widespread funding...
  
  Research & Development
  
  Taiho spends $400 million with a Swiss partner to “turbocharge” three ADCs to the clinic
  
  Editorial Team - March 20, 2025 0
  
  Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Araris Biotech ADC linker platform in Switzerland. Araris collaborated with Taiho Pharmaceutical after...
  
  Research & Development
  
  Élancé Therapeutics Joins the Race to Develop Next-Generation Obesity Therapies
  
  Editorial Team - March 14, 2025 0
  
  China-based Harbour BioMed has recently announced the establishment of a new biotechnology company, Élancé Therapeutics. This initiative is focused on developing bispecific antibodies designed...
  
  Research & Development
  
  Roche Comes Out With Novel ‘Sequencing-By-Expansion’ Approach
  
  Editorial Team - February 25, 2025 0
  
  Roche has proposed a fresh kind of genetic analysis. This process, which the company refers to as sequencing-by-expansion, is a patented technique that involves...
Clinical
- Clinical
  
  VelaVigo Bio Strikes Second Major Licensing Agreement, Transfers Bispecific Rights to Ollin Biosciences
  
  Editorial Team - April 23, 2025 0
  
  In a continued series of strategic moves, VelaVigo Bio, a biotechnology firm based in Shanghai, has finalized its second significant transaction within a six-month...
  
  Clinical
  
  Lilly’s Orforglipron Demonstrates Semaglutide-Like Efficacy in Phase 3 Type 2 Diabetes Trial
  
  Editorial Team - April 18, 2025 0
  
  Eli Lilly’s oral GLP-1 receptor agonist orforglipron has met its primary efficacy endpoint in a Phase 3 trial, showing reductions in A1C and body...
  
  Clinical
  
  The late-stage research of Bristol Myers’ heart disease medication falls short of its primary objectives
  
  Editorial Team - April 17, 2025 0
  
  Bristol Myers Squibb disclosed that its drug stavartanate did not successfully improve functional capacity or symptom intensities in heart disease patients, thus failing to...
  
  Clinical
  
  Pfizer Decides Against Pursuing Lead Obesity Asset Amid Liver Safety Concerns
  
  Editorial Team - April 16, 2025 0
  
  Pfizer said that it had discovered a possible instance of medication-induced liver impairment and, as a result, would no longer be investing in the...
Commercial
- All Brand & Marketing
  
  Commercial
  
  Biolinq Secures $100 Million to Advance Glucose Biosensor and Expand Commercialization Plans
  
  Editorial Team - April 23, 2025 0
  
  Biolinq has announced the successful closure of a $100 million venture capital investment round aimed at finalizing the development of its wearable glucose biosensor....
  
  Commercial
  
  Sanofi Deepens Autoimmune Push with $1.8B AI Biotech Deal
  
  Editorial Team - April 18, 2025 0
  
  Sanofi’s ambition to become a dominant force in immunology continues to take shape, as the French pharmaceutical giant signs a deal worth up to...
  
  Commercial
  
  Merck Signs $493M Agreement to Use Cyprumed’s Oral Peptide Platform
  
  Editorial Team - April 17, 2025 0
  
  Merck & Co. is taking a significant step toward transforming its peptide therapies into convenient oral tablets through a licensing agreement worth up to...
Technology
- Technology
  
  J&J MedTech presents the first Ottava surgical robot clinical cases
  
  Editorial Team - April 17, 2025 0
  
  Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot through a minimally invasive gastric bypass procedure in Texas. The system...
  
  Commercial
  
  Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
  
  Editorial Team - October 23, 2024 0
  
  Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal imbalances, resulting in irregular weight patterns. Wisp’s new weight care...
  
  Technology
  
  PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
  
  Editorial Team - September 26, 2024 0
  
  Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...
  
  Technology
  
  Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
  
  Editorial Team - August 8, 2024 0
  
  Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...
Insights
- Insights
  
  The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption
  
  Renato Rjavec - December 1, 2024 0
  
  A new independent survey of senior US pharma regulatory professionals suggests that commitment to AI investment is much higher than might be expected, although...
  
  Insights
  
  Improving life science R&D outcomes with AI
  
  Ben Sidders - November 8, 2024 0
  
  Maximizing the potential AI/data-driven model of drug discovery requires the technology’s full integration into R&D. Biorelate’s Dr Ben Sidders explains. Pharma R&D latest disruption is...
  
  Insights
  
  The medical device sector’s surging regulatory burden: how are suppliers coping?
  
  Mike Baird , Peter Muller - October 12, 2024 0
  
  Regulators around the world are increasing their scrutiny of medical devices as these become more critical to patient outcomes. Referencing new research, Peter Muller...
  
  Insights
  
  The Future of Gene Therapies: Three Trends
  
  Philip Cyr, Richard Macaulay , Andy Kinley - March 18, 2023 0
  
  “Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...
Podcast
Awards
- Winners of LSV Top Industry Leaders Award 2024
- List of Winners of the Rising Stars Award 2024
More

Viridian Drug Successfully Meets Study Objectives as Treatment for Thyroid Eye Disease

Clinical Editorial Team - September 11, 2024 0

Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug, recorded impressive...

Trump’s Proposed Pharmaceutical Tariffs May Potentially Drive Up Prices and Deepen Drug Shortages

Regulatory Editorial Team - April 11, 2025 0

The U.S. may soon impose significant tariffs on pharmaceutical imports, according to President Donald...

Mekonos closes $25M funding round for cell therapy platform

Research & Development Editorial Team - December 5, 2021 0

Mekonos closes funding of $25M in a series a round as it...

Roche offers $50 billion to US pharma production in response to the tariff threat

Manufacturing Editorial Team - April 24, 2025 0

Roche, the drugmaker giant, announced its interest in investing $50 billion over five years...

Biolinq Secures $100 Million to Advance Glucose Biosensor and Expand Commercialization Plans

Commercial Editorial Team - April 23, 2025 0

Biolinq has announced the successful closure of a $100 million venture capital investment round...

VelaVigo Bio Strikes Second Major Licensing Agreement, Transfers Bispecific Rights to Ollin Biosciences

Clinical Editorial Team - April 23, 2025 0

In a continued series of strategic moves, VelaVigo Bio, a biotechnology firm based in...

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

LifeNewsLife Science

LifeNewsFashion Trends and Culture

LifeSciVoiceFashion Trends and Culture

LifeNewsFashion Trends and Culture

Editor Picks

Must Read

Hot Topics

LifeSciVoice

About Us

Follow Us